CytoSorbents Leadership

Phillip Chan is a Co-Founder at Andrew Technologies and Board Member at Andrew Technologies and is based in New York City, New York. He has worked as Partner at Njtc Venture Fund Sbic, Chief Executive Officer and President at CYTOSORBENTS CORP, and Board Member at CYTOSORBENTS CORP. Phillip studied at Cornell between 1988 and 1992, Harvard Medical School between 2000 and 2003, and Yale University-School of Medicine between 1992 and 2000.

Kathleen 'Kathy' Bloch is a Chief Financial Officer at CYTOSORBENTS CORP and Chief Financial Officer at Pioneer Consulting Group, Inc. and is based in Princeton, New Jersey. She has experience at Silverman Group and KPMG and has worked as Chief Operating Officer at Pioneer Consulting Group, Inc.; Chief Financial Officer at Silver Line Building Products; and Chief Financial Officer at Laureate Biopharma Svcs Inc. Kathleen works or has worked at KPMG Peat Marwick. She attended LaSalle University.

Accomplished executive skilled at managing both start-up ventures and mature medical device, imaging, and pharmaceutical businesses. Valued for the ability to manage people and projects in highly technical and regulated environments. Solid financial, analytical, purchasing, regulatory and problem-solving capability, with extensive experience in plant expansion/consolidation and corporate re-engineering. Strong interpersonal and communication skills, known for success in leading, mentoring, and motivating teams to consistently achieve corporate objectives.

Senior health scientist with professional experience in clinical medicine, academic research and executive management and an established presence in the global CV and thrombosis stage.

Industry leadership roles in competitive strategy, business development, medical affairs, R&D (FDA AdCom and SAG presenter) and "big data" clinical and economic outcomes research.

Phillip Chan is a Co-Founder at Andrew Technologies and Board Member at Andrew Technologies and is based in New York City, New York. He has worked as Partner at Njtc Venture Fund Sbic, Chief Executive Officer and President at CYTOSORBENTS CORP, and Board Member at CYTOSORBENTS CORP. Phillip studied at Cornell between 1988 and 1992, Harvard Medical School between 2000 and 2003, and Yale University-School of Medicine between 1992 and 2000.